June 23

‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi

first_img STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. ‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi General Assignment Reporter Liz focuses on cancer, biomedical engineering, and how patients feel the effects of Covid-19. What is it? By Elizabeth Cooney May 26, 2020 Reprints About the Author Reprints What’s included? Peter Adamson joined Sanofi in late March, as the coronavirus pandemic surged around the world and changed lives and livelihoods. Someday, he says, he’ll take up his new role in Cambridge, Mass., as global development therapeutic area head for oncology in general and pediatric innovation in particular, but for now he is leading and learning from his home in South Jersey.A pediatric oncologist, Adamson spent the last 30 years caring for children and doing cancer research. He was a professor of pediatrics and pharmacology at the Perelman School of Medicine at the University of Pennsylvania and at the Children’s Hospital of Pennsylvania (CHOP). For the past 10 years, he chaired the Children’s Oncology Group, an international consortium supported by the National Cancer Institute whose 230 members carry out translational research and large-scale clinical trials in children and adolescents with cancer.  Business GET STARTEDcenter_img Elizabeth Cooney Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+. First 30 days free. GET STARTED @cooney_liz Kristoffer Tripplaar/Sipa via AP Images [email protected] Log In | Learn More Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tags Bostoncancerdrug developmentpediatricsSTAT+last_img

Tags: , , , , , , , , , , ,
Copyright 2021. All rights reserved.

Posted June 23, 2021 by admin in category "gwuspnofx

Leave a Reply

Your email address will not be published. Required fields are marked *